Dai ichi Life Insurance Company Ltd Grows Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Dai ichi Life Insurance Company Ltd boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 63.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,646 shares of the biotechnology company’s stock after acquiring an additional 1,418 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Axon Enterprise were worth $1,457,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. CIBC Asset Management Inc grew its holdings in shares of Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise in the 3rd quarter worth $221,000. Sequoia Financial Advisors LLC increased its position in shares of Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after acquiring an additional 81 shares during the period. Axxcess Wealth Management LLC bought a new position in shares of Axon Enterprise during the third quarter valued at about $814,000. Finally, Jag Capital Management LLC boosted its holdings in shares of Axon Enterprise by 9.7% during the third quarter. Jag Capital Management LLC now owns 56,086 shares of the biotechnology company’s stock worth $22,412,000 after purchasing an additional 4,954 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Jeri Williams sold 110 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $400.00, for a total value of $44,000.00. Following the transaction, the director now directly owns 1,934 shares of the company’s stock, valued at approximately $773,600. This represents a 5.38 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 50,000 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $364.02, for a total value of $18,201,000.00. Following the completion of the transaction, the chief executive officer now owns 2,980,861 shares of the company’s stock, valued at $1,085,093,021.22. This represents a 1.65 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 260,256 shares of company stock worth $105,984,120 in the last 90 days. Insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $634.96 on Thursday. The company has a 50 day simple moving average of $473.23 and a two-hundred day simple moving average of $372.97. Axon Enterprise, Inc. has a fifty-two week low of $224.28 and a fifty-two week high of $641.20. The company has a market capitalization of $48.42 billion, a price-to-earnings ratio of 164.07, a P/E/G ratio of 13.62 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC upped their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. JMP Securities raised their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Finally, Barclays raised their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.